Related Experiment Video
Updated: Aug 10, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
[Pain control in terminal cancer]
1Hospice, Yodogawa Christian Hospital.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 1, 1989
Summary
Effective cancer pain management involves a stepwise approach to analgesic drug therapy. Correctly administered nonopioid and opioid analgesics, alongside careful patient monitoring, are crucial for managing pain in advanced cancer patients.
Area of Science:
- Oncology
- Palliative Care
- Pharmacology
Context:
- Pain significantly impacts over two-thirds of advanced cancer patients.
- Effective pain control is essential for improving the quality of life for terminally ill cancer patients.
- Analgesic drug therapy is the cornerstone of cancer pain management.
Purpose:
- To outline the principles of effective analgesic drug therapy for cancer pain.
- To guide healthcare professionals in selecting and administering appropriate pain medications.
- To emphasize the importance of individualized treatment and patient monitoring.
Summary:
- Cancer pain management relies on a systematic approach, starting with nonopioid analgesics for mild to moderate pain (e.g., NSAIDs, acetaminophen).
- For severe pain, strong opioids (e.g., morphine, buprenorphine) are indicated, potentially with co-analgesics.
- Accurate patient assessment, correct drug selection, appropriate dosing, and regular monitoring are vital for treatment efficacy and managing side effects.
Impact:
- Properly managed cancer pain enhances patient well-being and quality of life during terminal illness.
- Correct application of analgesic therapy achieves effective pain relief in over 90% of cancer patients.
- Close patient supervision ensures ongoing pain control and proactive management of adverse effects.
Related Concept Videos
01:29Blood and Nerve Supply to the Bones
Bones are dynamic organs that require a rich supply of oxygen and nutrients. Around 5% to 10% of the cardiac output supplies blood to the bones. A typical long bone has three main sources: the nutrient artery, the metaphyseal and epiphyseal arteries, and the periosteal arteries.
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
Nutrient Artery
The nutrient artery is the main blood vessel that enters the diaphysis via the nutrient foramen. While most long bones have only one nutrient foramen, large bones, such as the femur, may have two. This...
01:25Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...